{"slideshow_credits": null, "snippet": "Hoping to win a six-month extension of protection from generic competition, the maker of OxyContin is renewing a clinical trial.", "abstract": "Purdue Pharma, maker of the widely abused narcotic painkiller OxyContin, is renewing a clinical trial of the drug's use in children; Purdue is hoping to use the study to obtain a lucrative six-month extension of OxyContin's protection from generic competition, making use of a 1990s law that rewards drug makers for conducting clinical studies involving children.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Barry", "role": "reported", "lastname": "MEIER", "rank": 1, "organization": ""}], "original": "By BARRY MEIER", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html", "lead_paragraph": "Hoping to win a six-month extension of protection from generic competition, the maker of OxyContin is renewing a clinical trial.", "headline": {"seo": "OxyContin\u2019s Effect on Children in Testing by Purdue Pharma", "main": "After Delay, OxyContin\u2019s Use in Young Is Under Study", "print_headline": "After Delay, OxyContin\u2019s Use in Young Under Study"}, "_id": "51c219097e0d9c0839d2a33b", "word_count": "966", "multimedia": [{"height": 75, "url": "images/2012/07/07/business/Pain/Pain-thumbStandard.jpg", "legacy": {"thumbnail": "images/2012/07/07/business/Pain/Pain-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2012-07-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Purdue Pharma", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "OxyContin (Drug)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Pain-Relieving Drugs", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Children and Childhood", "name": "subject", "is_major": "Y", "rank": "4"}, {"value": "Law and Legislation", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "6"}, {"value": "Generic Brands and Products", "name": "subject", "is_major": "Y", "rank": "7"}, {"value": "Clinical Trials", "name": "subject", "is_major": "N", "rank": "8"}], "blog": [], "subsection_name": null, "type_of_material": "News"}